News | April 10, 2008

St. Jude Medical $92M Acquisition Accelerates Afib Programs

April 11, 2008 - St. Jude Medical will acquire EP MedSystems for approximately $92.1 million in a deal that will accelerate St. Jude Medical's atrial fibrillation program and entry into the high-growth intracardiac ultrasound echocardiography (ICE) market.

Under the terms of the merger agreement, EP MedSystems shareholders will receive $3.00 of consideration for each EP MedSystems share they own, with the option of receiving that amount in cash or St. Jude Medical common stock.

In connection with this transaction, St. Jude Medical's Board of Directors has approved an additional stock buyback authorization of $50 million, which increases St. Jude Medical's share repurchase authorization from $250 million to $300 million. The additional buyback authorization will be used to offset the shares issued in this transaction.

The companies anticipate this acquisition will close during the third quarter of 2008. In connection with this transaction, St. Jude Medical will record a special charge for in-process research and development. This acquisition does not change St. Jude Medical's existing guidance for 2008 earnings per share, exclusive of the special charge.

Upon completion, this transaction will immediately add two new growth drivers to St. Jude Medical's program for products used in atrial fibrillation (AF) and other electrophysiology (EP) catheterization procedures. This includes the EP-WorkMate computerized electrophysiology workstation with a fully integrated EP-4 Computerized Cardiac Stimulator and expansion options to incorporate the NurseMate Remote Review Charting Station. The EP-WorkMate platform already enjoys a strong number two share of the global market for EP recording systems in spite of limited sales and marketing resources.

This transaction will also expedite St. Jude Medical's entry into the high-growth intracardiac ultrasound echocardiography (ICE) market with the EP MedSystems ViewMate II intracardiac ultrasound system and the next generation ViewFlex PLUS ICE catheter scheduled for market release this quarter. This market is growing at an estimated 25 percent to 30 percent per year and includes both electrophysiology and interventional cardiology applications.

The transaction is subject to certain closing conditions and regulatory approvals, and approval by EP MedSystems shareholders. Following the close of the transaction, Bruce is expected to join St. Jude Medical, and EP MedSystems will become part of the Atrial Fibrillation division of St. Jude Medical.

For more information: www. sjm.com

Related Content

Videos | EP Mapping and Imaging Systems| October 24, 2017
This video, provided by Acutus Medical, demonstrates a patient case showing the use of the AcQMap high-resolution ele
Acutus Medical Receives FDA Clearance for AcQMap Cardiac Mapping Technology
Technology | EP Mapping and Imaging Systems| October 24, 2017
Acutus Medical announced that the U.S. Food and Drug Administration (FDA) has cleared the AcQMap High Resolution...
Acutus Medical Announces Completion of Enrollment for UNCOVER AF Study
News | EP Mapping and Imaging Systems| May 02, 2017
Acutus Medical recently announced that enrollment has been completed in its pivotal Utilizing Novel Dipole Density...
Videos | EP Mapping and Imaging Systems| February 01, 2017
This video, provided by Medtronic, demonstrates the CardioInsight electro-anatomical mapping system.
medtronic cardioinsight electromapping system, electoanatomical mapping, noninvasive ep mapping

A screen shot of the waveforms and the the 3-D electo-mapping models created using the noninvasive CardioInsight system.

Technology | EP Mapping and Imaging Systems| February 01, 2017
February 1, 2017 — Medtronic received U.S.
BioSig Technologies, Pure EP system, JACC Clinical Electrophysiology, Journal of the American College of Cardiology, Purkinje Network
News | EP Mapping and Imaging Systems| January 16, 2017
January 16, 2017 — BioSig Technologies Inc. announced that the company’s Pure EP System, a novel cardiac...
St. Jude Medical, EnSite Precision cardiac mapping system, FDA clearance, catheter ablation
Technology | EP Mapping and Imaging Systems| January 03, 2017
St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) clearance of its EnSite Precision™ cardiac...
Acutus Medical, AcQMap High Resolution Imaging and Mapping System, atrial fibrillation, UNCOVER-AF trial, first procedure
News | EP Mapping and Imaging Systems| October 27, 2016
Acutus Medical announced the completion of the first patient procedure in the “Utilizing Novel Dipole Density...
St. Jude Medical, Ensite Precision cardiac mapping system, full European market release
News | EP Mapping and Imaging Systems| October 06, 2016
St. Jude Medical Inc. announced a full market release of its EnSite Precision cardiac mapping system and new Sensor...
Abbott, FIRM-guided rotor ablation, atrial fibrillation, clinical studies, Cardiostim 2016
News | EP Mapping and Imaging Systems| July 07, 2016
July 7, 2016 — Abbott recently announced positive results from three clinical studies investigating the benefits asso
Overlay Init